CSMS# 14-000409 - FDA Entry information for finished dosage drug products
U.S. Customs and Border Protection sent this bulletin at 07/11/2014 01:55 PM EDTYou are subscribed to Automated Broker Interface for U.S. Customs and Border Protection. This information has recently been updated, and is now available.
07/11/2014 02:54 PM EDT
Automated Broker Interface
FROM: US FOOD AND DRUG ADMINISTRATION
As part of the normal import screening process for finished dosage drug products, FDA does verify the status of the API manufacturer. While this verification is part of the normal entry review process performed by FDA, brokers are not required to provide the API manufacturer when filing entry for a finished dosage drug product. However, there may be instances when brokers are requested to verify the source of the API used to manufacture the finish dosage product being offered for entry.
If there are any questions please contact FDA’s Division of Import Operations at 301-796-0356
FROM: US FOOD AND DRUG ADMINISTRATION
As part of the normal import screening process for finished dosage drug products, FDA does verify the status of the API manufacturer. While this verification is part of the normal entry review process performed by FDA, brokers are not required to provide the API manufacturer when filing entry for a finished dosage drug product. However, there may be instances when brokers are requested to verify the source of the API used to manufacture the finish dosage product being offered for entry.
If there are any questions please contact FDA’s Division of Import Operations at 301-796-0356
Update your subscriptions, modify your password or e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact subscriberhelp.govdelivery.com.
This service is provided to you at no charge by U.S. Customs and Border Protection.
Privacy Policy | GovDelivery is providing this information on behalf of U.S. Department of Homeland Security, and may not use the information for any other purposes.
 |
 |